SGA
Sector Gamma AS Portfolio holdings
AUM
$306M
This Quarter Return
-3.59%
1 Year Return
+4.68%
3 Year Return
+19.67%
5 Year Return
+46.47%
10 Year Return
+161.43%
AUM
$501M
AUM Growth
+$501M
(-11%)
Cap. Flow
-$46.1M
Cap. Flow
% of AUM
-9.21%
Top 10 Holdings %
Top 10 Hldgs %
56.05%
Holding
39
New
2
Increased
14
Reduced
13
Closed
10
Top Buys
| 1 |
Merck
MRK
|
$26.8M |
| 2 |
Dentsply Sirona
XRAY
|
$14.6M |
| 3 |
Qiagen
QGEN
|
$8.79M |
| 4 |
Cardinal Health
CAH
|
$7.65M |
| 5 |
Boston Scientific
BSX
|
$7.21M |
Top Sells
| 1 |
Pfizer
PFE
|
$21M |
| 2 |
Gilead Sciences
GILD
|
$14.4M |
| 3 |
Henry Schein
HSIC
|
$12.3M |
| 4 |
Revvity
RVTY
|
$10.4M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$9.84M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Merck
MRK
$210B
| $61.1M | 12.18% | 812,814 +357,367 | +78% | +$26.8M |
|
|
2
Pfizer
PFE
$141B
| $28M | 5.59% | 651,600 -488,385 | -43% | -$21M |
|
3
Bristol-Myers Squibb
BMY
$96B
| $26.3M | 5.25% | 445,010 -78,483 | -15% | -$4.64M |
|
|
4
Boston Scientific
BSX
$156B
| $26.2M | 5.22% | 602,682 +166,276 | +38% | +$7.21M |
|
|
5
Gilead Sciences
GILD
$140B
| $25.9M | 5.17% | 371,085 -206,283 | -36% | -$14.4M |
|
|
6
Cardinal Health
CAH
$35.5B
| $25.9M | 5.17% | 523,606 +154,675 | +42% | +$7.65M |
|
7
Biogen
BIIB
$19.4B
| $23.6M | 4.7% | 83,319 +10,276 | +14% | +$2.91M |
|
8
Medtronic
MDT
$119B
| $23.2M | 4.62% | 184,700 -24,428 | -12% | -$3.06M |
|
9
Incyte
INCY
$16.5B
| $20.8M | 4.15% | 302,739 +18,594 | +7% | +$1.28M |
|
10
Becton Dickinson
BDX
$55.3B
| $20.1M | 4% | 81,593 -13,088 | -14% | -$3.22M |
|
11
Baxter International
BAX
$12.7B
| $19.1M | 3.81% | 237,429 +44,690 | +23% | +$3.59M |
|
12
Bruker
BRKR
$5.16B
| $18.2M | 3.63% | 233,252 -73,398 | -24% | -$5.73M |
|
13
Organon & Co
OGN
$2.45B
| $17.9M | 3.57% | 546,062 -6,170 | -1% | -$202K |
|
|
NUVA
14
DELISTED
NuVasive, Inc.
NUVA
| $17.9M | 3.56% | 298,426 +4,672 | +2% | +$280K |
|
|
15
Qiagen
QGEN
$10.1B
| $17.1M | 3.4% | 330,220 +170,159 | +106% | +$8.79M |
|
16
Elevance Health
ELV
$71.8B
| $16.1M | 3.21% | 43,192 -1,432 | -3% | -$534K |
|
17
CVS Health
CVS
$92.8B
| $14.9M | 2.98% | 176,120 -24,321 | -12% | -$2.06M |
|
|
18
Dentsply Sirona
XRAY
$2.85B
| $14.6M | 2.91% | +251,330 | New | +$14.6M |
|
19
Centene
CNC
$14.3B
| $13.2M | 2.64% | 212,223 -17,187 | -7% | -$1.07M |
|
20
Elanco Animal Health
ELAN
$9.12B
| $13.1M | 2.61% | 409,731 +13,253 | +3% | +$423K |
|
21
Labcorp
LH
$23.1B
| $10.7M | 2.13% | 37,858 -5,689 | -13% | -$1.6M |
|
22
Ionis Pharmaceuticals
IONS
$6.79B
| $8.85M | 1.77% | 263,870 +382 | +0.1% | +$12.8K |
|
23
Bio-Rad Laboratories Class A
BIO
$8.06B
| $8.4M | 1.67% | 11,255 -4,881 | -30% | -$3.64M |
|
24
Universal Health Services
UHS
$11.6B
| $6.96M | 1.39% | 50,295 +21,084 | +72% | +$2.92M |
|
25
Rigel Pharmaceuticals
RIGL
$697M
| $6.44M | 1.28% | 1,772,730 +67,177 | +4% | +$244K |
|